EDMUND KING
CIK 1198425 · Chief Financial Officer · last filed 2016-04-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.76M
Companies
2
Total Filings
38
Lifetime Open-Market Net
-$1.13M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LTC | Director | 42,101 | $41.77 | $1.76M | -$1.13M | 24 | 2015-05-29 |
| ACCENTIA BIOPHARMACEUTICALS INC (ABPI) Delisted | Director | — | — | — | $0 | 1 | 2008-03-04 |
Recent Filings · Page 3 of 4
38 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2010-09-27 | LTC | Sell (S) | −3,000 | -$77.5K | EDGAR |
| 2010-08-20 | — | Grant (A) | — | $0 | |
| 2010-08-20 | — | Grant (A) | — | $0 | |
| 2010-06-01 | LTC | Grant (A) | +1,000 | $25.9K | EDGAR |
| 2010-03-17 | LTC | Mixed | +866 | $1.1K | EDGAR |
| 2009-09-14 | LTC | Gift (G) | −1,000 | -$24.6K | EDGAR |
| 2009-08-11 | LTC | Disp (D) | −1,500 | -$37.5K | EDGAR |
| 2009-05-20 | LTC | Grant (A) | −1,000 | -$18.3K | EDGAR |
| 2008-12-31 | LTC | Gift (G) | −1,200 | -$24.3K | EDGAR |
| 2008-08-06 | LTC | Sell (S) | −3,000 | -$87.0K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.